If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

Thu, 16th Sep 2021 07:33

* Holders of roughly 75% Vectura shares tender support

* PMI needed 50% backing for deal to go through

* Extends deadline for other holders to tender shares by
Sept. 30
(Adds detail, background)

By Pushkala Aripaka

Sept 16 (Reuters) - Cigarette maker Philip Morris (PMI)
has clinched the roughly 1-billion-pound takeover of
inhaler maker Vectura after winning the backing of about
75% of shareholders in the British company, part of its
expansion beyond tobacco.

Vectura shareholders had until Sept. 15 to decide whether to
support the 165 pence-per-share bid from PMI, which sought to
buy the London-listed asthma drug maker as part of its plan to
go "smoke-free" and switch to healthcare and wellness products.

"We have reached an important milestone in our acquisition
of Vectura and are pleased to have secured over 74% of the
company's shares, in excess of the 50% required to make our
offer unconditional and PMI the majority shareholder," PMI Chief
Executive Jacek Olczak said in a statement on Thursday.

PMI had received the shares from shareholders through a
public tender offer process, and the cigarette maker's offer for
Vectura cannot be withdrawn now.

PMI, which fought off private equity firm Carlyle Group
for the buyout of Vectura, had switched its proposal to a
takeover offer from a so-called scheme of arrangement to raise
its chances.

The switch allowed PMI to require the support of holders of
just over 50% of Vectura shares for the deal to go through.

Philip Morris has received regulatory clearances for the
deal and had won the backing of Vectura's board, but health
groups are questioning the idea of a tobacco company making
money from treating the very illnesses that cigarettes cause.

Olczak said PMI would provide Vectura's scientists with the
resources and expertise to reach a target of at least $1 billion
in net revenue from its "Beyond Nicotine" products by 2025.

The U.S.-based company has also extended the deadline for
the remaining Vectura shareholders to tender their shares to
Sept. 30.

($1 = 0.7234 pounds)
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Devika
Syamnath and Emelia Sithole-Matarise)

More News
9 Jul 2021 07:31

UPDATE 2-Marlboro maker Philip Morris to buy UK drugmaker in 'beyond nicotine' push

* Vectura withdraws support for Carlyle deal* UK firm recommends Philip Morris offer* Deal is second by Philip Morris in a week* Shares jump nearly 13% (Recasts, adds detail, background)July 9 (Reuters) - Marlboro cigarettes maker Philip Morris Int...

Read more
9 Jul 2021 07:02

Philip Morris swoops for Vectura Group with £1bn bid

(Sharecast News) - Tobacco giant Philip Morris on Friday swooped for UK pharmaceuticals company Vectura Group with a £1.045bn recommended offer.

Read more
5 Jul 2021 15:23

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
18 Jun 2021 13:01

Vectura sets meeting date for GBP958 million takeover by Carlyle

Vectura sets meeting date for GBP958 million takeover by Carlyle

Read more
10 Jun 2021 10:35

Vectura completes management buy-out of Skyepharma Production unit

Vectura completes management buy-out of Skyepharma Production unit

Read more
4 Jun 2021 15:56

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
27 May 2021 17:27

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

Read more
27 May 2021 09:32

BROKER RATINGS: Barclays raises Aveva; HSBC says Buy Severn Trent

BROKER RATINGS: Barclays raises Aveva; HSBC says Buy Severn Trent

Read more
27 May 2021 08:45

LONDON MARKET OPEN: Stocks muted but more M&A spark in London

LONDON MARKET OPEN: Stocks muted but more M&A spark in London

Read more
27 May 2021 07:56

LONDON MARKET PRE-OPEN: Aviva in strong quarter; Equiniti backs bid

LONDON MARKET PRE-OPEN: Aviva in strong quarter; Equiniti backs bid

Read more
26 May 2021 17:10

LONDON MARKET CLOSE: Stocks mixed; Vectura surges on takeover

LONDON MARKET CLOSE: Stocks mixed; Vectura surges on takeover

Read more
26 May 2021 13:43

LIVE MARKETS-UK travel reopening kick-starts airlines

* European STOXX index flat* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomson...

Read more
26 May 2021 12:45

LIVE MARKETS-ECB: mini-tapering worries

* European Stoxx index down 0.1%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@th...

Read more
26 May 2021 12:05

LONDON MARKET MIDDAY: Lacklustre moves but FTSE 250 outperforms on M&A

LONDON MARKET MIDDAY: Lacklustre moves but FTSE 250 outperforms on M&A

Read more
26 May 2021 12:02

LIVE MARKETS-DIY hedging

* European shares erase gains* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thoms...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.